Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $63,097 | 38 | 49.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $41,040 | 34 | 32.2% |
| Travel and Lodging | $19,279 | 63 | 15.1% |
| Food and Beverage | $4,009 | 63 | 3.1% |
| Education | $98.98 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Insmed, Inc. | $127,425 | 198 | $0 (2024) |
| Astellas Pharma US Inc | $98.98 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $650.00 | 1 | Insmed, Inc. ($650.00) |
| 2023 | $24,022 | 32 | Insmed, Inc. ($24,022) |
| 2022 | $30,758 | 38 | Insmed, Inc. ($30,758) |
| 2021 | $14,052 | 26 | Insmed, Inc. ($14,052) |
| 2020 | $20,564 | 34 | Insmed, Inc. ($20,564) |
| 2019 | $37,408 | 68 | Insmed, Inc. ($37,379) |
| 2017 | $69.99 | 1 | Astellas Pharma US Inc ($69.99) |
All Payment Transactions
200 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/13/2024 | Insmed, Inc. | — | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| 11/24/2023 | Insmed, Inc. | Arikayce (Drug) | Consulting Fee | Cash or cash equivalent | $912.00 | General |
| Category: Respiratory | ||||||
| 10/05/2023 | Insmed, Inc. | Arikayce (Drug) | Consulting Fee | Cash or cash equivalent | $440.00 | General |
| Category: Respiratory | ||||||
| 09/26/2023 | Insmed, Inc. | Arikayce (Drug) | Consulting Fee | Cash or cash equivalent | $1,540.00 | General |
| Category: Respiratory | ||||||
| 09/26/2023 | Insmed, Inc. | Arikayce (Drug) | Consulting Fee | Cash or cash equivalent | $880.00 | General |
| Category: Respiratory | ||||||
| 09/26/2023 | Insmed, Inc. | Arikayce (Drug) | Travel and Lodging | In-kind items and services | $563.00 | General |
| Category: Respiratory | ||||||
| 09/26/2023 | Insmed, Inc. | Arikayce (Drug) | Travel and Lodging | In-kind items and services | $395.53 | General |
| Category: Respiratory | ||||||
| 09/26/2023 | Insmed, Inc. | Arikayce (Drug) | Travel and Lodging | In-kind items and services | $332.71 | General |
| Category: Respiratory | ||||||
| 09/26/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $270.69 | General |
| Category: Respiratory | ||||||
| 09/26/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $149.67 | General |
| Category: Respiratory | ||||||
| 09/26/2023 | Insmed, Inc. | Arikayce (Drug) | Travel and Lodging | In-kind items and services | $81.21 | General |
| Category: Respiratory | ||||||
| 09/25/2023 | Insmed, Inc. | Arikayce (Drug) | Consulting Fee | Cash or cash equivalent | $3,740.00 | General |
| Category: Respiratory | ||||||
| 08/01/2023 | Insmed, Inc. | Arikayce (Drug) | Consulting Fee | Cash or cash equivalent | $3,740.00 | General |
| Category: Respiratory | ||||||
| 08/01/2023 | Insmed, Inc. | Arikayce (Drug) | Travel and Lodging | In-kind items and services | $287.22 | General |
| Category: Respiratory | ||||||
| 08/01/2023 | Insmed, Inc. | Arikayce (Drug) | Travel and Lodging | In-kind items and services | $258.89 | General |
| Category: Respiratory | ||||||
| 08/01/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $124.88 | General |
| Category: Respiratory | ||||||
| 08/01/2023 | Insmed, Inc. | Arikayce (Drug) | Travel and Lodging | In-kind items and services | $44.00 | General |
| Category: Respiratory | ||||||
| 08/01/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Respiratory | ||||||
| 04/20/2023 | Insmed, Inc. | Arikayce (Drug) | Consulting Fee | Cash or cash equivalent | $440.00 | General |
| Category: Respiratory | ||||||
| 04/04/2023 | Insmed, Inc. | Arikayce (Drug) | Consulting Fee | Cash or cash equivalent | $440.00 | General |
| Category: Respiratory | ||||||
| 03/22/2023 | Insmed, Inc. | Arikayce (Drug) | Consulting Fee | Cash or cash equivalent | $2,420.00 | General |
| Category: Respiratory | ||||||
| 03/22/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $67.03 | General |
| Category: Respiratory | ||||||
| 03/21/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $5.85 | General |
| Category: Respiratory | ||||||
| 03/10/2023 | Insmed, Inc. | Arikayce (Drug) | Consulting Fee | Cash or cash equivalent | $1,540.00 | General |
| Category: Respiratory | ||||||
| 03/10/2023 | Insmed, Inc. | Arikayce (Drug) | Consulting Fee | Cash or cash equivalent | $440.00 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 143 | 226 | $96,570 | $22,720 |
| 2022 | 5 | 104 | 149 | $70,415 | $16,717 |
| 2021 | 5 | 96 | 164 | $67,158 | $16,468 |
| 2020 | 5 | 121 | 208 | $73,492 | $18,873 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 67 | $28,676 | $6,531 | 22.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 36 | 61 | $24,278 | $5,889 | 24.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 34 | $20,400 | $4,844 | 23.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 25 | 44 | $11,616 | $2,767 | 23.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 20 | $11,600 | $2,689 | 23.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 36 | 61 | $20,374 | $4,787 | 23.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 25 | $14,950 | $3,736 | 25.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 21 | 21 | $13,587 | $3,271 | 24.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 30 | $12,720 | $2,927 | 23.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $8,784 | $1,997 | 22.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 38 | 81 | $27,054 | $6,740 | 24.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 25 | $15,050 | $3,704 | 24.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 18 | $11,754 | $2,917 | 24.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 20 | $8,620 | $1,991 | 23.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 14 | 20 | $4,680 | $1,117 | 23.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 48 | 85 | $28,220 | $7,390 | 26.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 20 | 20 | $12,900 | $3,280 | 25.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 26 | 52 | $12,012 | $3,214 | 26.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 11 | 23 | $10,672 | $2,520 | 23.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 16 | 28 | $9,688 | $2,468 | 25.5% |
About Dr. Wendi Drummond, D.O
Dr. Wendi Drummond, D.O is a Infectious Disease healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1417160797.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wendi Drummond, D.O has received a total of $127,524 in payments from pharmaceutical and medical device companies, with $650.00 received in 2024. These payments were reported across 200 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($63,097).
As a Medicare-enrolled provider, Drummond has provided services to 464 Medicare beneficiaries, totaling 747 services with total Medicare billing of $74,777. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Location Portland, OR
- Active Since 05/07/2007
- Last Updated 03/09/2021
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1417160797
Products in Payments
- Arikayce (Drug) $115,844
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Portland
Kevin Winthrop, Md, MD
Infectious Disease — Payments: $2.7M
Mr. David Gilbert, Md, MD
Infectious Disease — Payments: $27,605
Kieren Marr
Infectious Disease — Payments: $18,569
Paul Sehdev, Md, MD
Infectious Disease — Payments: $13,123
Dr. Phil Alday, Md, Phd, MD, PHD
Infectious Disease — Payments: $8,943
Sunwen Chou, Md, MD
Infectious Disease — Payments: $1,817